US9828361B2ActiveUtilityPatentIndex 92
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
Est. expiryFeb 11, 2030(~3.6 yrs left)· nominal 20-yr term from priority
Inventors:MAN HON-WAHCHEN ROGER SHEN-CHUMULLER GEORGE WRUCHELMAN ALEXANDER LKHALIL EHAB MZHANG WEIHONG
A61P 43/00A61P 37/02A61P 9/14A61P 7/06A61P 9/10A61P 39/02A61P 37/04A61P 9/00A61P 7/00A61P 31/18A61P 25/00A61P 25/20A61P 25/04A61P 31/00A61P 27/02A61P 35/00A61P 29/00A61P 33/00A61P 17/00A61P 19/02A61P 11/00A61P 21/00C07D 417/14C07D 409/14C07D 487/04C07D 401/12C07D 407/12C07D 493/04C07D 471/04C07D 491/107C07D 401/04C07D 495/04C07D 413/14C07D 407/14C07D 401/14A61K 31/4412C07D 498/08C07D 405/14A61P 7/04
92
PatentIndex Score
12
Cited by
66
References
10
Claims
Abstract
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula:
or a pharmaceutically acceptable salt or stereoisomer thereof.
2. The compound of claim 1 , which is
or a pharmaceutically acceptable salt thereof.
3. The compound of claim 2 , which is
4. The compound of claim 1 , which is
or a pharmaceutically acceptable salt thereof.
5. The compound of claim 4 , which is
6. A pharmaceutical composition comprising a compound of claim 1 and one or more excipients.
7. A pharmaceutical composition comprising a compound of claim 2 and one or more excipients.
8. A pharmaceutical composition comprising a compound of claim 3 and one or more excipients.
9. A pharmaceutical composition comprising a compound of claim 4 and one or more excipients.
10. A pharmaceutical composition comprising a compound of claim 5 and one or more excipients.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.